Nektar Therapeutics Inc (NKTR)
20.03
-0.27 -1.31%
NASDAQ
Dec 5, 10:03
Delayed 2m
USD
Nektar Therapeutics Underperform Recommendations
View 4,000+ financial data types
Browse...
View Full Chart
Underperform Recommendations Chart
Historical Underperform Recommendations Data
View and export this data going back to 2014.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Nov. 12, 2019 | Upgrade |
| Nov. 11, 2019 | Upgrade |
| Nov. 10, 2019 | Upgrade |
| Nov. 8, 2019 | Upgrade |
| Nov. 7, 2019 | Upgrade |
| Nov. 4, 2019 | Upgrade |
| Oct. 28, 2019 | Upgrade |
| Oct. 24, 2019 | Upgrade |
| Oct. 23, 2019 | Upgrade |
| Oct. 21, 2019 | Upgrade |
| Oct. 16, 2019 | Upgrade |
| Oct. 8, 2019 | Upgrade |
| Sept. 30, 2019 | Upgrade |
| Sept. 27, 2019 | Upgrade |
| Sept. 26, 2019 | Upgrade |
| Sept. 19, 2019 | Upgrade |
| Sept. 17, 2019 | Upgrade |
| Sept. 16, 2019 | Upgrade |
| Sept. 11, 2019 | Upgrade |
| Sept. 9, 2019 | Upgrade |
| Aug. 30, 2019 | Upgrade |
| Aug. 27, 2019 | Upgrade |
| Aug. 21, 2019 | Upgrade |
| Aug. 20, 2019 | Upgrade |
| Aug. 16, 2019 | Upgrade |
| Aug. 13, 2019 | Upgrade |
| Aug. 9, 2019 | Upgrade |
| Aug. 8, 2019 | Upgrade |
| Aug. 1, 2019 | Upgrade |
| July 26, 2019 | Upgrade |
| July 25, 2019 | Upgrade |
| July 18, 2019 | Upgrade |
| July 15, 2019 | Upgrade |
| June 27, 2019 | Upgrade |
| June 14, 2019 | Upgrade |
| June 13, 2019 | Upgrade |
| June 6, 2019 | Upgrade |
| June 4, 2019 | Upgrade |
| June 3, 2019 | Upgrade |
| June 2, 2019 | Upgrade |
| May 30, 2019 | Upgrade |
| May 24, 2019 | Upgrade |
| May 23, 2019 | Upgrade |
| May 17, 2019 | Upgrade |
| May 16, 2019 | Upgrade |
| May 14, 2019 | Upgrade |
| May 13, 2019 | Upgrade |
| May 10, 2019 | Upgrade |
| May 9, 2019 | Upgrade |
| May 6, 2019 | Upgrade |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
View Underperform Recommendations for NKTR
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.
Start My Free Trial
No credit card required.
Already a subscriber? Sign in.
Underperform Recommendations Benchmarks
| Benchmarks | |
|---|---|
| Bristol-Myers Squibb Co | Upgrade |
| Johnson & Johnson | Upgrade |
| Pfizer Inc | Upgrade |
Underperform Recommendations Range, Past 5 Years
| Minimum | Upgrade | Jun 01 2015 |
| Maximum | Upgrade | Jan 16 2015 |
| Average | Upgrade |
News
Nektar to Webcast Presentation at Jefferies 2019 London Healthcare Conference
PR Newswire 11/13 17:30 ET
PR Newswire 11/13 17:30 ET
